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Abstract
Background: We are conducting a genetic study of autism in the isolated population of the
Central Valley of Costa Rica (CVCR). A novel Neuregulin 1 (NRG1) missense variant (exon 11
G>T) was recently associated with psychosis and schizophrenia (SCZ) in the same population
isolate.
Methods: We genotyped the NRG1 exon 11 missense variant in 146 cases with autism, or autism
spectrum disorder, with CVCR ancestry, and both parents when available (N = 267 parents) from
143 independent families. Additional microsatellites were genotyped to examine haplotypes
bearing the exon 11 variant.
Results: The NRG1 exon 11 G>T variant was found in 4/146 cases including one de novo
occurrence. The frequency of the variant in case chromosomes was 0.014 and 0.045 in the parental
non-transmitted chromosomes. At least 6 haplotypes extending 0.229 Mb were associated with the
T allele. Three independent individuals, with no personal or family history of psychiatric disorder,
shared at least a 1 megabase haplotype 5' to the T allele.
Conclusion: The NRG1 exon 11 missense variant is not associated with autism in the CVCR.
Background
We are conducting a population genetic study of autism in
the CVCR [1]. Recently, Walss-Bass et al. [2] reported that
they had identified a novel missense variant in the trans-
membrane domain of Neuregulin 1 (Val>Leu in exon 11)
associated with the phenotypes of psychosis (SCZ and
psychotic mood disorder) and SCZ in the CVCR. The cases
apparently descended from a common ancestor who
migrated to Costa Rica from Spain and was born in 1670.
Genome-wide linkage studies of autism have not high-
lighted chromosome 8p12, where NRG1 is located, and
autism is not characterized by psychosis. However, both
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of the Reelin (RELN) gene (reviewed in Fatemi 2005 [3]).
Additionally, deletions of 22q11.2 are associated both
with autism and psychosis [4,5] and another group dem-
onstrated that offspring of parents with psychosis or affec-
tive disorders had a greater risk of developing autism [6].
Finally, SCZ is widely present in the relatives of our autism
probands and these probands have been ascertained from
the CVCR as in the Walss-Bass study. Given these data sug-
gesting a common genetic basis for at least a subset of
autism and SCZ subjects, and the shared ancestry of the
autism and SCZ probands in both studies, we decided to




We are collecting autism trios with the goal of performing
a population genetic study of autism in the isolated
founder population of the CVCR. As this population was
founded by a small number of individuals in the 16th cen-
tury, and grew exponentially in isolation until the 1970s,
disease alleles present at the founding should be widely
distributed in the current population. This project was
approved under the guidelines of the Ministry of Health
of Costa Rica, the Ethical committee of the National Chil-
dren's Hospital in San Jose (Hospital Nacional de Ninos
or HNN), and the Institutional Review Board at Mount
Sinai School of Medicine in accordance with the Declara-
tion of Helsinki. These approvals remain active.
Details of the case ascertainment and evaluation process
have been previously described [1]. Briefly, families of
individuals with possible autism contact us, or are con-
tacted by us after expressing interest in the study, and are
formally asked to participate using established informed
consent criteria. All interviews and exams take place in the
Neurodevelopmental Unit of the HNN. Possibly affected
individuals and their parents are interviewed by experi-
enced neuropediatricians using the Autism Diagnostic
Interview Revised (ADI-R) [7]. The Autism Diagnostic
Observation Schedule (ADOS) [8] is also administered to
subjects and both of these assessments are videotaped for
independent scoring by the best estimators. IQ tests are
administered that are appropriate for the age and level of
verbal communication of the subjects. The Vineland
Adaptive Behavioral Scales [9] are administered and com-
pared with the results of IQ tests to confirm diagnoses of
mental retardation.
All subjects are evaluated with a complete medical and
neurological examination, including a dermatological
examination with Wood's Lamp to look for signs of tuber-
ous sclerosis and Hypomelanosis of Ito. All subjects in
this study have been reported negative for FRAXA muta-
tions and subjects with mental retardation were reported
to have normal G-banded karyotypes at 550-band resolu-
tion.
Subjects were included in this study if they met DSM IV-
TR [10] criteria for autism in all three symptom domains
(social interaction, communication or language, and
behavioural abnormalities) as measured by the ADI-R and
the ADOS. Additionally, age of onset for at least one
symptom domain must have been less than 36 months. A
diagnosis of autism spectrum was given to individuals
who met ADI-R criteria but had an age of onset greater
than 36 months, or were no more than one point below
ADI-R criteria for autism in the social domain, and in
either the communication or repetitive behaviour
domains, but not in both, or if they met full criteria using
the ADI-R but were one point below the cut-off score for
autism in one domain of the ADOS. We also included
subjects with a DSM IV-TR diagnosis of Asperger's Syn-
drome. Although we will not include probands with a
DSM IV-TR diagnosis of Pervasive Developmental Disor-
der Not Otherwise Specified (PDD-NOS) in a future
whole genome association study of autism, we did
include them in this exploratory study. Subjects with a
nonverbal IQ <35 were excluded unless they had an adap-
tive behaviour score much higher than the IQ measure.
This is because there are no local Costa Rican norms for
IQ testing and thus IQ may be underestimated in this
population [1].
All individuals also had to have CVCR ancestry defined as
having at least 6/8 great-grandparents (GGPs) born in the
CVCR, or all 4 GGPs from either the maternal or paternal
side (in which case only transmission from the parent
with CVCR ancestry is considered). Furthermore, individ-
uals cannot be related by fewer than 6 generations,
although we did genotype siblings, if affected, in the cur-
rent study. The sample genotyped for this study includes
143 independent families. There were 129 cases with
autism, 67% of which also had a diagnosis of mental
retardation. The rest of the cases did not have mental
retardation and included N = 7 with autism spectrum dis-
order, N = 4 with PDD-NOS, and N = 3 with Asperger's
Syndrome. Three autism cases also had siblings with
either PDD-NOS (2), or autism (1). The mean age of the
subjects was 5.75 years and the range was 3–13. Sixteen of
the 143 cases were female. The three multiplex families
consisted of two male sib pairs and one male:female sib
pair.
Genotyping
A TaqMan SNP genotyping assay was designed using ABI
Assay-by-Design File Builder Version 2.0 from the follow-
ing genomic sequence:Page 2 of 5
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The sequences used for the amplification primers are as
follows: Forward primer, TGCATCGCCCTCCTTGTG;
Reverse primer, AGAAAGGCATGGAGAAAGAAGGTTT.
Identification of the G allele was accomplished using the
probe CACCACACACATGAT-8 labelled with VIC. Identi-
fication of the T allele was performed using CCAC-
CAAACACATGAT-8 labelled with FAM. The SNP
Genotyping Assay Mix was obtained from Applied Biosys-
tems (Foster City, CA) at a concentration of 40×, and
diluted to 20× with 1× TE. For each reaction, 2.50 µl of 2×
TaqMan Universal PCR Master Mix, No AmpErase UNG
(Applied Biosystems, Foster City, CA), 0.25 ul of 20× SNP
Genotyping Assay Mix, and 2.25 µl of genomic DNA at 10
ng/µl were used for a total reaction volume of 5 µl using
384-well plates. The plates were run in the ABI 7900 ther-
mal cycler with the following conditions: 95°C for 10
minutes hold, then 40 cycles of 15 second denaturation at
92°C and 1 minute of annealing/extension at 60°C. At
the completion of the amplification and the absolute
quantification read, the allelic discrimination assay read
was performed to generate the allelic discrimination read
file to be analyzed on SDS 2.1.
Microsatellite markers for haplotype analysis included
317J8-2123, D8S1810, 420M9-1395 and 487-2. Details
regarding genotyping of these microsatellites are available
upon request. Note that the order of these markers has
changed in the Human Genome Browser March 2006
assembly since the publication of NRG1 haplotypes by Li
et al. [10]. D8S1810 and 420M9-1395 have switched
positions. Details regarding the microsatellite markers we
utilized are available at deCODE Genetics [14].
Results
Frequency of the exon 11 missense variant in cases and 
parental non-transmitted chromosomes
The exon 11 missense variant was present in two cases
diagnosed with autism, one case diagnosed with an
autism spectrum disorder (one point below one domain
of the ADI-R), and one case diagnosed with PDD NOS, in
addition to co-morbid attention deficit hyperactivity dis-
order and a tongue tic (Case 129). The allele was transmit-
ted from the mother in all cases but appears to have
occurred de novo in Case 129. The missense allele was
also present in 12 unrelated, other than by marriage,
parental individuals, 7 fathers and 5 mothers, from 11
families who did not transmit the allele to cases. To be
clear, both parents of Case 25 carry the T allele and they
are not related to each other by fewer than 6 generations.
The frequency of the allele in the non-transmitted chro-
mosomes was therefore 12/267 = 0.045, remarkably close
to the frequency estimate of 0.042 by Walss-Bass et al [2].
Haplotype analysis revealed the presence of 6 haplotypes
carrying the missense T allele when considering only the
closest microsatellite 317J8-2123, 0.229 Mb proximal to
the exon 11 missense variant (Table 1). Please see Figure
1 for the position of microsatellite markers typed in rela-
tion to the exon 11 variant. After microsatellite 317J8-
2123, the next closest markers are clustered together with
D8S1810 at ~0.964 Mb upstream followed by 420M9-
1395 and then 487-2 ~1.04 Mb upstream from the first
marker. These three 5' markers were typed as most associ-
ations to NRG1 with SCZ have been to markers in this
region. Three parental chromosomes from 3 independent
families (one transmitted to a case and the other two non-
transmitted) shared alleles at all 4 microsatellite markers
typed over a distance of ~1.04 Mb (Table 1). Two other
independent parental non-transmitted chromosomes also
may share a different ~1.04 Mb haplotype however phase
is uncertain.
Psychiatric history of exon 11 missense variant carriers
We take a careful family psychiatric history on first, sec-
ond and third degree relatives of all probands. Therefore,
we reviewed the psychiatric history of all cases as well as
persons carrying the T allele to look for the presence of
psychotic or affective disorders. None of the 12 'T' carrier
non-transmitting parents had a psychiatric disorder. How-
ever, AU025C, a 40 year old mother did have a sister with
manic-depression and, AU113C, a 38 year old mother,
did have a brother who had been hospitalized with SCZ
(unfortunately DNA samples could not be obtained on
these subjects). This inheritance pattern could represent
incomplete penetrance in carriers of the missense allele.
However, 113C and 25C did not share a haplotype with
each other. Of note, 7 trios not segregating the T allele had
a blood-related aunt or uncle with schizophrenia, which
were not available for testing. An 8th case had a parent
Position of the microsatellite markers genotyped in NRG1Figure 1
Position of the microsatellite markers genotyped in 
NRG1. Diagram not to scale with regards to the position of 
exons.Page 3 of 5
(page number not for citation purposes)
BMC Psychiatry 2007, 7:21 http://www.biomedcentral.com/1471-244X/7/21with SCZ who did not carry the T allele and a parental sib
with SCZ whose carrier status is unknown. A 9th autism
case had more than one first degree relative with SCZ, nei-
ther of whom carried the T allele. None of the three T-
allele transmitting parents had a personal or family his-
tory of psychotic or affective disorders. Finally, Case 129
appears to carry a de novo occurrence of the T allele as we
have observed no other non-mendelian transmissions
from either parent to Case 129 in a panel of markers span-
ning chromosomes 15, 7, 17, 21 and 4 which should
effectively rule out non-paternity.
Discussion
Our major conclusion is that the NRG1 missense variant
is not associated with autism in our sample. However, can
we conclude anything about a relationship of this allele to
SCZ or psychosis from our results?
Walss-Bass et al. [12] first genotyped 6 of 7 markers previ-
ously observed to be associated with SCZ in Iceland [13]
in a sample of 134 trios with a history of psychosis includ-
ing 94 cases diagnosed with SCZ, 16 cases with schizoaf-
fective bipolar disorder, 4 cases with schizoaffective
disorder depressed, 5 cases with major depressive episode
accompanied by psychosis and 3 cases with psychosis not
otherwise specified. They further stratified their sample
into SCZ (N = 114), manic psychosis (N = 63), and non-
manic psychosis cases. They did not find statistically sig-
nificant evidence for over-transmission of alleles or hap-
lotypes containing markers from the 'deCode' haplotype
after correcting for multiple testing. However, they
reported a trend (p < 0.05 uncorrected for multiple test-
ing) towards over transmission of the most common 4
marker haplotype that they observed in their sample (f =
0.168), to cases with manic psychosis. Similarly, alleles at
the two microsatellite markers in this core haplotype were
not significantly associated with manic psychosis after
correction for multiple testing.
Walss-Bass et al. [2] subsequently selected the 12 individ-
uals with a history of SCZ or psychosis and mania that car-
ried alleles representing the most common haplotype
observed in cases for sequencing. They found a G>T poly-
morphism in exon 11 resulting in a Val>Leu missense
change observed in 1 of the 12 cases. However, this exon
11 variant was not in LD with the haplotype that they used
to guide their search for a disease polymorphism so it may
represent a serendipidous finding. They next genotyped
the exon 11 variant in 378 individuals from 151 different
CVCR families, 142 of whom were affected with psycho-
sis. The T allele was transmitted 13 times from hetero-
zygous parents to affected individuals and not transmitted
4 times yielding a significant association with psychosis
(Z = 2.810, p = 0.0049) and with SCZ (Z = 2.383, p =
Table 1: Microsatellite haplotypes observed in exon 11 missense variant carriers.
Family ID A/B/C/D 487-2 D8S1810 420M9-1395 317J8-2123 Exon 11 G>T T/NT Hap# Comment
AU025 25B 247.5 194 190 240 T NT 1
AU025 25C 235.7 192 202 247 T NT 2 Sister with bipolar disorder
AU027 27C 247.5 194 (190) 246 T NT 3 Possible extended hap
AU044 44C 247.5 (194) 190 246 T NT 3 Possible extended hap
AU058 58A 245.7 176 181 247 T T 2
AU058 58C 245.7 176 181 247 T T 2
AU058 58D2 245.7 176 181 247 T T 2
AU059 59A 235.7 196 202 242 T T 4
AU059 59C 235.7 196 202 242 T T 4
AU061 61B 237.7 178 181 242 T NT 4 Extended hap
AU071 71B 237.7 178 181 242 T NT 4 Extended hap
AU090 90A 237.7 178 181 242 T T 4 Extended hap
AU090 90C 237.7 178 181 242 T T 4
AU089 89C 246.4 176 181 242 T NT 4 Extended hap w recomb?
AU113 113C 253.1 178 186 242 T NT 4 Brother with SCZ
AU129 129A 235.7 194 202 246 T NT 3 De novo in case
AU143 143B 243.8 194 202 253 T NT 5
AU164 164B 241.8 178 186 253 T NT 5
AU165 165B 239.7 196 190 238 T NT 6
The first column contains the family ID number of the autism proband. The second column indicates the family member status, for example 25A 
signifies the case, 25B signifies the father, 25C signifies the mother and 58D2 indicates the second sibling of case 58. The next 4 columns contain 
alleles from the 4 microsatellites genotyped to determine which haplotypes are associated with the rare 'T' allele. Alleles were binned where 
possible with the exception of marker 478–642 wherein the allele is called as reported by the software. Brackets around an allele mean that phase 
could not be determined with certainty. The "T/NT" column indicates whether the haplotype was transmitted, or not transmitted, from a parent to 
a case, or the sibling of a case. The "Hap#" column indicates the number of different haplotype backgrounds associated with the 'T' allele 
considering only the closest microsatellite 317J8-2123 (0.229 Mb away). The comment column notes extended haplotypes > ~1 Mb A question 
mark next to the haplotype number indicates that the haplotype background could not be determined with certainty.Page 4 of 5
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0.0191) using the Family-based Association Test (FBAT).
The authors then found genealogical connections linking
the families transmitting the T-allele to one common
Spanish founder. Our data do show evidence of a possible
founder effect surrounding the T-allele in 3 independent
individuals (and possibly in another 2 independent indi-
viduals) however none of those families were segregating
SCZ.
Conclusion
In summary, our data does not support a relationship of
the NRG1 exon 11 missense variant with either autism or
SCZ in the CVCR, although it does not reduce support for
the previous association with SCZ either. Further studies
examining the frequency of the exon 11 T allele in control
individuals from the CVCR, and LD in the vicinity of the
exon 11 variant should help determine whether the NRG1
allele actually does contribute to psychosis in this popula-
tion.
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